-
"Pharmaceutical Express" AZ Dagli net new adaptation was approved Lilly Q3 global revenue of $5.741 billion
Time of Update: 2020-11-10
October 28, 2020 / Pharmaceutical Information At a Glance: Pfizer's oral JAK1 inhibitors are eligible for FDA priority review; NMPA approves AstraZenega's net new adaptation; Jiahe Bio submits an application for the listing of Invlich mono-biosimilars; Lilly Q3's global total revenue of $5,741 million; and the resignation of the Chairman of North China Pharmaceuticals...
-
Konda new material main industry continued to make efforts in the first half of the net profit of revenue increased significantly
Time of Update: 2020-10-20
's 2019 financial results show that Kanda New Materials achieved revenue of RMB431 million, up 26.15% YoY, while net income attributable to shareholders of listed companies was RMB58.666 million, up 48.32% YoY, and basic earnings per share was RMB0.197, compared with RMB0.169.
-
Well-known big three to start a rigorous review activities to thoroughly investigate the doctor's lecture fees
Time of Update: 2020-10-04
If you find out which fee is paid by which company on the doctor's account, the hospital disciplinary inspection committee will send a letter of assistance to the corresponding pharmaceutical company, requiring the company to provide, on a case-by-case basis, the invitation letter, teaching courseware, on-site photos, labor agreement, transfer card number, the amount involved, the schedule of the meeting and other relevant supporting materials.
-
Two true stories of the 2020 Drug Tender Jun
Time of Update: 2020-08-26
in the three years of work time, the small generation of hard work, let the blame, from a budding college students to grow into the company's recognized backbone in bidding.
-
Libang's parent company has acquired a Chinese furniture and coatings company
Time of Update: 2020-08-25
Through its Chinese subsidiary, Sun Tu Holdings acquired a 60% stake in the paint company, strengthening its coatings business for residential decoration in China and expanding sales to furniture companies and others.
-
South America: "Medical" tourists set off a "boom
Time of Update: 2020-07-07
Editor's Note: A $15,000 rapoperation in the U.S costs about $5,000 in Argentina, and a breast-thoracic liposuction combination costs just $3,700 With attractive exchange rates and cheap plastic su
-
Inventory: global research and development of stem cell products
Time of Update: 2019-11-24
Author: Stem cell therapy refers to a new science and technology of injecting stem cells or their products from autogenous or allogeneic sources into human body to achieve the purpose of disease treat
-
Don't be angry at will, because anger is related to all kinds of old age diseases
Time of Update: 2019-06-11
June 11, 2019 / BIOON / - not all negative emotions are bad In fact, they can guide your behavior in useful ways If you're late in a traffic jam, anger at the situation may prompt you to find another
-
Fluoxetine consistency evaluation: Shanghai Pharmaceutical ranked first in 6.7 billion market
Time of Update: 2018-08-15
On August 13th, Shanghai pharmaceutical announced that its holding subsidiary, Sinopharm, recently received the approval document for drug supplement application of Fluoxetine Hydrochloride Capsules (
-
Ma Xingtian, chairman of Kangmei Pharmaceutical Co., Ltd. won the leader award of "fit Guangdong" science and innovation pioneer competition
Time of Update: 2018-05-15
[China Pharmaceutical network enterprise news] on May 12, the "power of example - 2017 'fit Guangdong' science and technology innovation pioneer Competition Award Ceremony" jointly sponsored by China
-
[flash news] April 13, 2018 EU Copyright Reform annoys scientists | India punishes plagiarism classification system
Time of Update: 2018-04-13
The EU Copyright Reform has angered scientists that an influential committee of the European Parliament is about to vote this month on the reform of the EU's internal copyright law However, the latest
-
Delegation of China Association for the promotion of drugs to attend "2017 Asia Pacific biotechnology Investment Forum
Time of Update: 2017-12-08
Source: China pharmaceutical innovation promotion association 2017-12-08 December 6, 2017, "2017 Asia Pacific biotechnology Investment Forum" (2017 Asia Pacific biotechnology Investment Forum), sponso
-
Pharmaceutical pattern changes again, Roche reaches the summit in 2022, with Novartis and Pfizer in the second and third places
Time of Update: 2016-09-19
Source: pharmaceutical economic news 2016-09-19, evaluatepharma released the latest report "2016 global pharmaceutical outlook", which predicted the development trend of the global pharmaceutical indu
-
Sun Xianze, deputy director of CFDA: it's time to speed up the consistency evaluation of generic drugs
Time of Update: 2016-08-23
Source: e-medicine manager, August 20, 2016, sun Xianze, deputy director of the State Food and drug administration, pointed out: "the consistency evaluation of quality and efficacy of generic drugs in
-
Novartis is accused of paying $25 million in bribes in China to reach a settlement
Time of Update: 2016-03-25
Source: Medical Rubik's cube data 2016-03-25 US Securities and Exchange Commission (SEC) announced on March 23 that Novartis has agreed to pay US $25 million to settle a previously received civil laws
